U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. News & Events for Human Drugs
  4. From Our Perspective
  1. News & Events for Human Drugs

From Our Perspective

Risk Evaluation and Mitigation Strategies (REMS)
Part 2 - Implementation: Challenges and Opportunities

By: Claudia Manzo, Director, Office of Medication Error Prevention and Risk Management, Office of Surveillance and Epidemiology, Centers for Drug Evaluation and Research

Risk Evaluation and Mitigation Strategy (REMS) programs focus on preventing, monitoring, and/or managing a specific serious risk(s) associated with certain drugs by informing, educating, and/or reinforcing actions to reduce the frequency and/or severity of a particular adverse event(s). As discussed in Part 1, there are several key participants who play important roles in the medication use process for drugs that are subject to REMS.

More with Claudia Manzo

 

Resources for You

Back to Top